| Literature DB >> 6247190 |
P Schelling, D Ganten, Z Nemes, H Fischer.
Abstract
The effects of angiotensin II and of the competitive angiotensin II receptor antagonist saralasin on in vivo tumor growth were investigated in hamsters. Angiotensin II strongly inhibited tumor growth while saralasin stimulated it, though the high dose used had partial agonistic angiotensin II-like actions. Lower doses of saralasin were without significant effect on tumor weights.Entities:
Mesh：
Substances：
Year: 1980 PMID： 6247190 DOI： 10.1007/bf01975143
Source DB: PubMed Journal: Experientia ISSN： 0014-4754